Results 71 to 80 of about 5,834 (144)

Refractory hyperactivity and Batten's disease – A Case Report

Archives of Mental Health, 2016
Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder of neurodevelopmental type characterized by inattentiveness, hyperactivity and impulsiveness.
Narayan R Mutalik, Vinayak Koparde, Devaraddi Navalli   +2 more
doaj  

Special edition: The NCLs/Batten disease [PDF]

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
Rahim, AA, Russell, C, Mole, SE
openaire   +3 more sources

Application of Anticonvulsants, Antiepileptic Drugs, and Vitamin C in the Treatment and Analysis of Batten Disease. [PDF]

Cureus, 2022
Reddy S, Brahmbhatt H.
europepmc   +1 more source

The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample. [PDF]

Eur J Paediatr Neurol, 2022
Wibbeler E, Nickel M, Schwering C, Schulz A, Mink JW.   +4 more
europepmc   +1 more source

PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy. [PDF]

NeuroImmune Pharm Ther
Chandra S, Pahan K.
europepmc   +1 more source

Recommendations for the diagnosis and management of cln3 disease (batten disease) using the Delphi consensus methodology. [PDF]

Orphanet J Rare Dis
Mink JW, Adams HR, Ahrens-Nicklas R, Andersen BN, Augustine E, Boustany RM, Cooper JD, Levin A, Gissen P, Laine M, Mason HL, Mole SE, Nickel M, Ostergaard JR, Sikorra L, Treat L, Whiteman IT, Williams R, Schulz A.   +18 more
europepmc   +1 more source

Extracellular Vesicles Released by Genetically Modified Macrophages Activate Autophagy and Produce Potent Neuroprotection in Mouse Model of Lysosomal Storage Disorder, Batten Disease. [PDF]

Cells, 2023
El-Hage N, Haney MJ, Zhao Y, Rodriguez M, Wu Z, Liu M, Swain CJ, Yuan H, Batrakova EV.   +8 more
europepmc   +1 more source

Value of genetic testing for pediatric epilepsy: Driving earlier diagnosis of ceroid lipofuscinosis type 2 Batten disease. [PDF]

Epilepsia, 2022
Leal-Pardinas F, Truty R, McKnight DA, Johnson B, Morales A, Bristow SL, Yar Pang T, Cohen-Pfeffer J, Izzo E, Sankar R, Koh S, Wirrell EC, Millichap JJ, Aradhya S.   +13 more
europepmc   +1 more source

Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease. [PDF]

Nucleic Acids Res
Stratton MP, Centa JL, Swier VJ, Pfeifer WL, Booth CD, Albert K, Hunyara JL, Rechtzigel MJ, Duelli FJ, Leppert HG, Rigo F, Smit T, Jafar-Nejad P, Weimer JM, Drack AV, Hastings ML.   +15 more
europepmc   +1 more source

An Unusual Presentation of CLN3-Associated Batten Disease With Classic Histopathologic and Ultrastructural Findings. [PDF]

J Neuropathol Exp Neurol, 2021
Evans LP, Gibson-Corley KN, Mullins RF, Tucker BA, Trent A, Stone EM, Jones KA.   +6 more
europepmc   +1 more source